Pharma Reviews: Coronavirus crisis: It's time for India Inc to create opportunities

Indian pharma industry is dependent on Chinese imports to make medicines — the APIs (active pharma ingredients) come from China. The $30 billion ...
Read more: Coronavirus crisis: It's time for India Inc to create opportunities